...
首页> 外文期刊>Clinical and experimental rheumatology >The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP 205-220) antibody in the saliva of patients with primary sj?gren's syndrome
【24h】

The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP 205-220) antibody in the saliva of patients with primary sj?gren's syndrome

机译:毒蕈碱型乙酰胆碱受体3型多肽(M3RP 205-220)抗体在原发性干燥综合征患者唾液中的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Sj?gren's syndrome (SS) is a chronic autoimmune disorder of unknown cause. Recent studies have shown that antimuscarinic acetylcholine type 3 receptor (M3R) antibodies can be detected in patients with Sj?gren's syndrome (SS), but little is known about the diagnostic value of this antibody. Objective To assess the clinical correlations of anti-M3R (muscarinic acetylcholine receptor type 3) polypeptide (M3RP 205-220) antibodies in saliva from patients of primary Sj?gren's syndrome (pSS). Methods Serum samples and unstimulated mixed saliva from 100 patients with SS were collected and examined. Their mean (SD) age was 54.2 (13.4) years, and the mean (SD) disease duration was 6.2 (3.8) years. Serum samples from 40 patients with systemic lupus erythematosus (SLE), 40 with rheumatoid arthritis (RA), and 60 healthy subjects were analysed as controls. All the patients with SS were carefully evaluated according to European and American criteria. A circular M3RP 205-220 peptide sequence was synthesized using solid-phase techniques on an applied biosytems peptide synthesizer. The correlation between anti-M3RP 205-220 antibodies and clinical manifestations of pSS was analysed. Results The IgG of anti-M3RP 205-220 antibodies was present in 69% of patients with pSS, 27.5% with SLE, 22.5% with RA, and 23.3% of normal saliva donors. The prevalence of anti-M3RP 205-220 antibodies in pSS was significantly higher than in SLE, RA, and normal controls. The specificity of anti-M3RP 205-220 antibodies in pSS was 75%. The salivary flow rate in the group positive for anti-M3RP 205-220 was 436 μl/10 min, compared to a rate of 658 μl/10 min for the negative group (p0.05). Conclusion The anti-M3RP 205-220 antibody was detected in most patients with pSS. The presence of the antibody was closely associated with the salivary flow rate. This indicated that it may act as an autoantigen, with a role in the pathogenesis of pSS.
机译:背景干燥综合征(SS)是一种原因不明的慢性自身免疫性疾病。最近的研究表明,在患有干燥综合征(SS)的患者中可以检测到抗毒蕈碱型3型乙酰胆碱受体(M3R)抗体,但对该抗体的诊断价值知之甚少。目的评估原发性干燥综合征(pSS)患者唾液中的抗M3R(毒蕈碱型乙酰胆碱受体3型)多肽(M3RP 205-220)抗体的临床相关性。方法收集100例SS患者的血清和未刺激的混合唾液并进行检查。他们的平均(SD)年龄为54.2(13.4)岁,平均疾病(SD)病程为6.2(3.8)年。分析来自40例系统性红斑狼疮(SLE),40例类风湿关节炎(RA)和60例健康受试者的血清样本作为对照。所有SS患者均根据欧洲和美国标准进行了仔细评估。使用固相技术在应用的生物系统肽合成仪上合成了环状M3RP 205-220肽序列。分析了抗M3RP 205-220抗体与pSS临床表现之间的相关性。结果抗M3RP 205-220抗体的IgG存在于69%的pSS患者,27.5%的SLE,22.5%的RA和23.3%的正常唾液供体中。 pSS中抗M3RP 205-220抗体的发生率显着高于SLE,RA和正常对照组。抗M3RP 205-220抗体在pSS中的特异性为75%。抗M3RP 205-220阳性组的唾液流速为436μl/ 10 min,而阴性组为658μl/ 10 min(p <0.05)。结论在大多数pSS患者中检测到抗M3RP 205-220抗体。抗体的存在与唾液流速密切相关。这表明它可能充当自身抗原,在pSS的发病机理中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号